000			01610 a2200397 4500
005			20250512103749.0
264		0	_c19670411
008			196704s 0 0 eng d
022			_a0083-8969
040			_aNLM _beng _cNLM
100	1		_aTaylor, J A
245	0	0	_aPharmacodynamic observations on metronidazole therapy. Side effects in endocrine, metabolic and auto-immune disorders. 3. Anti-ischemic and anti-inflammatory action in peripheral vascular disorders. _h[electronic resource]
260			_bProceedings of the Western Pharmacology Society _c1966
300			_a37-9 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article
650	0	4	_aBlood Circulation _xdrug effects
650	0	4	_aBlood Flow Velocity
650	0	4	_aBlood Pressure _xdrug effects
650	0	4	_aClinical Trials as Topic
650	0	4	_aDiabetes Complications
650	0	4	_aEndarteritis _xdrug therapy
650	0	4	_aErythema Nodosum _xcomplications
650	0	4	_aHumans
650	0	4	_aLupus Erythematosus, Systemic _xdrug therapy
650	0	4	_aMetronidazole _xtherapeutic use
650	0	4	_aPanniculitis, Nodular Nonsuppurative _xcomplications
650	0	4	_aPolyarteritis Nodosa _xdrug therapy
650	0	4	_aRadiation Injuries _xdrug therapy
650	0	4	_aRaynaud Disease _xdrug therapy
650	0	4	_aScleroderma, Systemic _xdrug therapy
650	0	4	_aSnake Bites _xdrug therapy
650	0	4	_aThrombosis _xdrug therapy
650	0	4	_aVaricose Ulcer _xdrug therapy
650	0	4	_aVascular Diseases _xdrug therapy
773	0		_tProceedings of the Western Pharmacology Society _gvol. 9 _gp. 37-9
999			_c4385867 _d4385867